Back to Search Start Over

Lipid and Lipoprotein Profiles in Youth With and Without Type 1 Diabetes.

Authors :
Guy, John
Ogden, Lorraine
Wadwa, R. Paul
Hamman, Richard F.
Mayer-Davis, Elizabeth J.
Liese, Angela D.
D'agostino Jr., Ralph
Marcovina, Santica
Dabelea, Dana
Source :
Diabetes Care; Mar2009, Vol. 32 Issue 3, p416-420, 5p, 2 Charts, 1 Graph
Publication Year :
2009

Abstract

OBJECTIVE -- The purpose of this study was to compare the lipid profile and the prevalence of lipid abnormalities in youth with and without type 1 diabetes and explore the role of glycemic control on the hypothesized altered lipid profile in youth with type 1 diabetes. RESEARCH DESIGN AND METHODS-- We conducted a cross-sectional analysis of 512 youth with type 1 diabetes (mean duration 4.22 years) and 188 healthy control subjects aged 10-22 years in Colorado and South Carolina. SEARCH for Diabetes in Youth (SEARCH) participants with type 1 diabetes and healthy control subjects recruited from primary care offices in the same geographic regions were invited to attend a research visit. Fasting lipid profiles were compared between youth with type 1 diabetes (stratified according to categories of optimal [A1C <7.5%] and suboptimal [A1C ≥ 7.5%] glycemic control) and healthy nondiabetic youth, using multiple linear and logistic regression. RESULTS -- Youth with type 1 diabetes and optimal A1C had lipid concentrations that were similar (total cholesterol, LDL cholesterol, and LDL particle size) or even less atherogenic (HDL cholesterol, non-HDL cholesterol, triglyceride, and triglyceride-to-HDL cholesterol ratio) than those observed in nondiabetic youth, whereas youth with suboptimal glycemic control had elevated standard lipid levels (total cholesterol, LDL cholesterol, and non-HDL cholesterol). Youth with type 1 diabetes also had significantly elevated apolipoprotein B levels and more small, dense LDL particles than nondiabetic youth, regardless of glycemic control. CONCLUSIONS -- Youth with type 1 diabetes have abnormal lipid levels and atherogenic changes in lipoprotein composition, even after a relatively short disease duration. As in adults, glycemic control is an important mediator of these abnormalities. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
01495992
Volume :
32
Issue :
3
Database :
Complementary Index
Journal :
Diabetes Care
Publication Type :
Academic Journal
Accession number :
37265255
Full Text :
https://doi.org/10.2337/dc08-1775